Hula

Benchmark Space Systems is building a low-cost propulsion system for the rapidly growing small satellite market. The company system uses a non-toxic, inert chemical that is safe to transport and store, making it attractive to a range of customers. The small satellite market is predicted to be $30B over the next 10 years, and propulsion is a key enabling technology for this growth. Their system also uses a proprietary, patent-pending system that will offer tremendous value by offering solid performance at a low cost. It proposes a resistor jet micro propulsion system that leverages a solid gas generator to offer high-performance, low-cost propulsion with key safety features. Benchmark Space Systems was founded in 2017 and is headquartered in South Burlington, VT, USA.

Reconciled is an online bookkeeping and accounting service designed for entrepreneurs and small businesses, allowing clients to concentrate on their core operations while handling daily accounting tasks. The company utilizes modern cloud accounting software and online tools to manage bookkeeping transactions efficiently. In addition to standard bookkeeping, Reconciled offers advanced Controller and CFO services for companies with more complex financial requirements. Founded by experienced entrepreneurs Michael Ly and Bonnie Reese, Reconciled emerged from the need for reliable remote accounting services, addressing frustrations associated with part-time bookkeepers. The firm employs only US-based accounting professionals, each possessing relevant qualifications and experience. Their team of Controllers and CFOs brings significant industry expertise, ensuring clients receive high-quality, consistent accounting support while streamlining and digitizing their financial workflows.

Biocogniv Inc. specializes in developing artificial intelligence-powered diagnostic tools tailored for hospitals. Founded in 2019 and based in Burlington, Vermont, the company creates plugins for electronic health records (EHRs) that enhance clinical decision-making. Its initial product screens patients for COVID-19 by rapidly analyzing standard blood test results, achieving a sensitivity rate of 95%. Additionally, Biocogniv's technology aims to predict sepsis-related in-hospital mortality and the need for intensive care unit admission during emergency department visits. By seamlessly integrating with EHR workflows, Biocogniv's solutions facilitate accurate and non-invasive diagnostic methods, thereby improving patient outcomes and operational efficiency in the medical sector.